Expert Review of Precision Medicine and Drug Development
Personalized medicine in drug development and clinical practice
Volume 5, 2020 - Issue 3
Editorial
How can bioinformatics contribute to the routine application of personalized precision medicine?
Carlos Carretero-Puchea Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain;b Laboratorio de Oncología Clínico-Traslacional, Unidad de Investigación en Tumores Digestivos, Instituto de Investigación I+12, Hospital 12 de Octubre, Madrid, Spain
https://orcid.org/0000-0003-0474-8668View further author information
https://orcid.org/0000-0003-0474-8668View further author information, Santiago García-Martína Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spainhttps://orcid.org/0000-0002-4540-9446View further author information
https://orcid.org/0000-0002-4540-9446View further author information, Rocío García-Carbonerob Laboratorio de Oncología Clínico-Traslacional, Unidad de Investigación en Tumores Digestivos, Instituto de Investigación I+12, Hospital 12 de Octubre, Madrid, Spainhttps://orcid.org/0000-0002-3342-397XView further author information
https://orcid.org/0000-0002-3342-397XView further author information, Gonzalo Gómez-Lópeza Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spainhttps://orcid.org/0000-0002-4146-0551View further author information
https://orcid.org/0000-0002-4146-0551View further author information & Fátima Al-Shahroura Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, SpainCorrespondence[email protected]
https://orcid.org/0000-0003-2373-769XView further author information
https://orcid.org/0000-0003-2373-769XView further author information